PRA4 is one of several forms of Progressive Retinal Atrophy identified in dogs. The disease typically develops slowly, and many affected dogs may not show obvious symptoms during the early stages. Initial signs often include difficulty seeing in low-light conditions or at night, commonly referred to as night blindness. As the disease progresses, dogs may begin to experience reduced daytime vision, increased hesitation in unfamiliar environments, bumping into objects, or difficulty navigating obstacles. In advanced stages, complete blindness can occur. Despite the loss of vision, PRA4 is generally not painful, and many dogs adapt remarkably well to their changing visual abilities.
Results are typically reported in one of three categories:
- Clear (Normal): The dog does not carry the PRA4 mutation and cannot pass it to its offspring.
- Carrier: The dog carries one copy of the mutation but is unlikely to develop the disease. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing PRA4-related retinal degeneration during its lifetime.
Genetic testing for PRA4 provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the disease within a breed while maintaining genetic diversity. By avoiding the breeding of two carrier dogs, the risk of producing affected puppies can be significantly reduced.
For pet owners, early knowledge of a dog's genetic status allows for proactive health monitoring and regular ophthalmic examinations. Although there is currently no cure that can stop or reverse PRA4-related retinal degeneration, early diagnosis helps owners prepare for potential vision changes and implement environmental adjustments that can improve a dog's quality of life.
The Progressive Retinal Atrophy (PRA4) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine eye health, and contributes to the long-term well-being of future generations of dogs. Through early detection and informed breeding strategies, the impact of this inherited eye disease can be effectively managed and reduced over time.
